The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis

被引:239
作者
Onizawa, Michio [1 ]
Oshima, Shigeru [1 ]
Schulze-Topphoff, Ulf [2 ]
Oses-Prieto, Juan A. [3 ]
Lu, Timothy [1 ]
Tavares, Rita [1 ]
Prodhomme, Thomas [2 ]
Duong, Bao [1 ]
Whang, Michael I. [1 ]
Advincula, Rommel [1 ]
Agelidis, Alex [1 ]
Barrera, Julio [1 ]
Wu, Hao [4 ]
Burlingame, Alma [3 ]
Malynn, Barbara A. [1 ]
Zamvil, Scott S. [2 ]
Ma, Averil [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[4] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Biol Chem & Mol Pharmacol,Program Cellular &, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; LINEAR POLYUBIQUITIN; PROGRAMMED NECROSIS; EXPRESSION; TNFAIP3; INFLAMMATION; REGULATOR; BINDING; RECOGNITION; DOWNSTREAM;
D O I
10.1038/ni.3172
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A20 is an anti-inflammatory protein linked to multiple human diseases; however, the mechanisms by which A20 prevents inflammatory disease are incompletely defined. We found that A20-deficient T cells and fibroblasts were susceptible to caspase-independent and kinase RIPK3-dependent necroptosis. Global deficiency in RIPK3 significantly restored the survival of A20-deficient mice. A20-deficient cells exhibited exaggerated formation of RIPK1-RIPK3 complexes. RIPK3 underwent physiological ubiquitination at Lys5 (K5), and this ubiquitination event supported the formation of RIPK1-RIPK3 complexes. Both the ubiquitination of RIPK3 and formation of the RIPK1-RIPK3 complex required the catalytic cysteine of A20's deubiquitinating motif. Our studies link A20 and the ubiquitination of RIPK3 to necroptotic cell death and suggest additional mechanisms by which A20 might prevent inflammatory disease.
引用
收藏
页码:618 / +
页数:11
相关论文
共 53 条
  • [1] Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
    Adrianto, Indra
    Wen, Feng
    Templeton, Amanda
    Wiley, Graham
    King, Jarrod B.
    Lessard, Christopher J.
    Bates, Jared S.
    Hu, Yanqing
    Kelly, Jennifer A.
    Kaufman, Kenneth M.
    Guthridge, Joel M.
    Alarcon-Riquelme, Marta E.
    Anaya, Juan-Manuel
    Bae, Sang-Cheol
    Bang, So-Young
    Boackle, Susan A.
    Brown, Elizabeth E.
    Petri, Michelle A.
    Gallant, Caroline
    Ramsey-Goldman, Rosalind
    Reveille, John D.
    Vila, Luis M.
    Criswell, Lindsey A.
    Edberg, Jeffrey C.
    Freedman, Barry I.
    Gregersen, Peter K.
    Gilkeson, Gary S.
    Jacob, Chaim O.
    James, Judith A.
    Kamen, Diane L.
    Kimberly, Robert P.
    Martin, Javier
    Merrill, Joan T.
    Niewold, Timothy B.
    Park, So-Yeon
    Pons-Estel, Bernardo A.
    Scofield, R. Hal
    Stevens, Anne M.
    Tsao, Betty P.
    Vyse, Timothy J.
    Langefeld, Carl D.
    Harley, John B.
    Moser, Kathy L.
    Webb, Carol F.
    Humphrey, Mary Beth
    Montgomery, Courtney Gray
    Gaffney, Patrick M.
    [J]. NATURE GENETICS, 2011, 43 (03) : 253 - U102
  • [2] Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations
    Bates, J. S.
    Lessard, C. J.
    Leon, J. M.
    Nguyen, T.
    Battiest, L. J.
    Rodgers, J.
    Kaufman, K. M.
    James, J. A.
    Gilkeson, G. S.
    Kelly, J. A.
    Humphrey, M. B.
    Harley, J. B.
    Gray-McGuire, C.
    Moser, K. L.
    Gaffney, P. M.
    [J]. GENES AND IMMUNITY, 2009, 10 (05) : 470 - 477
  • [3] cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination
    Bertrand, Mathieu J. M.
    Milutinovic, Snezana
    Dickson, Kathleen M.
    Ho, Wai Chi
    Boudreault, Alain
    Durkin, Jon
    Gillard, John W.
    Jaquith, James B.
    Morris, Stephen J.
    Barker, Philip A.
    [J]. MOLECULAR CELL, 2008, 30 (06) : 689 - 700
  • [4] Cellular Inhibitors of Apoptosis cIAP1 and cIAP2 Are Required for Innate Immunity Signaling by the Pattern Recognition Receptors NOD1 and NOD2
    Bertrand, Mathieu J. M.
    Doiron, Karine
    Labbe, Katherine
    Korneluk, Robert G.
    Barker, Philip A.
    Saleh, Maya
    [J]. IMMUNITY, 2009, 30 (06) : 789 - 801
  • [5] A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis
    Beyaert, R
    Heyninck, K
    Van Huffel, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) : 1143 - 1151
  • [6] The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
    Boone, DL
    Turer, EE
    Lee, EG
    Ahmad, RC
    Wheeler, MT
    Tsui, C
    Hurley, P
    Chien, M
    Chai, S
    Hitotsumatsu, O
    McNally, E
    Pickart, C
    Ma, A
    [J]. NATURE IMMUNOLOGY, 2004, 5 (10) : 1052 - 1060
  • [7] Ubiquitin Binding to A20 ZnF4 Is Required for Modulation of NF-κB Signaling
    Bosanac, Ivan
    Wertz, Ingrid E.
    Pan, Borlan
    Yu, Christine
    Kusam, Saritha
    Lam, Cynthia
    Phu, Lilian
    Phung, Qui
    Maurer, Brigitte
    Arnott, David
    Kirkpatrick, Donald S.
    Dixit, Vishva M.
    Hymowitz, Sarah G.
    [J]. MOLECULAR CELL, 2010, 40 (04) : 548 - 557
  • [8] A20 in inflammation and autoimmunity
    Catrysse, Leen
    Vereecke, Lars
    Beyaert, Rudi
    van Loo, Geert
    [J]. TRENDS IN IMMUNOLOGY, 2014, 35 (01) : 22 - 31
  • [9] Mechanisms of necroptosis in T cells
    Ch'en, Irene L.
    Tsau, Jennifer S.
    Molkentin, Jeffery D.
    Komatsu, Masaaki
    Hedrick, Stephen M.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (04) : 633 - 641
  • [10] Nonproteolytic Functions of Ubiquitin in Cell Signaling
    Chen, Zhijian J.
    Sun, Lijun J.
    [J]. MOLECULAR CELL, 2009, 33 (03) : 275 - 286